Inari Medical Inc
NASDAQ:NARI
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
37.11
65.8
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Inari Medical Inc
Wall Street
Price Targets
NARI Price Targets Summary
Inari Medical Inc
According to Wall Street analysts, the average 1-year price target for
NARI
is 68.19 USD
with a low forecast of 50.5 USD and a high forecast of 90.3 USD.
NARI Last Price Targets
Inari Medical Inc
The latest public price target was made on Oct 29, 2024 by
Richard Newitter
from
Truist Financial
,
who expects
NARI
stock to
drop by 7%
over the next 12 months.
You can read more about this price target by viewing
the article on StreetInsider.
| Analyst | Price Target | Date | Article |
|---|---|---|---|
Richard Newitter
Truist Financial
|
50
USD
Downside 7% |
1 month ago
Oct 29, 2024
|
Inari Medical Inc. (NARI) PT Raised to $50 at Truist Securities
StreetInsider
|
Adam Maeder
Piper Sandler
|
52
USD
Downside 3% |
1 month ago
Oct 29, 2024
|
Inari Medical price target raised to $52 from $50 at Piper Sandler
TheFly
|
|
Marie Thibault
BTIG
|
86
USD
Upside 60% |
1 month ago
Oct 29, 2024
|
BTIG Reiterates Buy Rating on Inari Medical Inc. (NARI)
StreetInsider
|
David Rescott
Robert W. Baird
|
67
USD
Upside 25% |
1 month ago
Oct 29, 2024
|
Inari Medical Inc. (NARI) PT Raised to $67 at Baird
StreetInsider
|
William Plovanic
Canaccord Genuity
|
74
USD
Upside 38% |
1 month ago
Oct 29, 2024
|
Inari Medical Inc. (NARI) PT Raised to $74 at Canaccord Genuity
StreetInsider
|
|
David Rescott
Robert W. Baird
|
66
USD
Upside 23% |
2 months ago
Oct 15, 2024
|
Inari Medical Inc. (NARI) PT Raised to $66 at Baird
StreetInsider
|
Mathew Blackman
Stifel Nicolaus
|
50
USD
Downside 7% |
3 months ago
Sep 17, 2024
|
Inari Medical initiated with a Hold at Stifel
TheFly
|
Pito Chickering
Deutsche Bank
|
68
USD
Upside 27% |
4 months ago
Aug 9, 2024
|
Deutsche Bank Starts Inari Medical Inc. (NARI) at Buy
StreetInsider
|
Larry Biegelsen
Wells Fargo
|
65
USD
Upside 21% |
4 months ago
Jul 31, 2024
|
Inari Medical price target lowered to $65 from $84 at Wells Fargo
TheFly
|
|
David Rescott
Robert W. Baird
|
63
USD
Upside 17% |
4 months ago
Jul 31, 2024
|
Inari Medical price target lowered to $63 from $65 at Baird
TheFly
|
|
Richard Newitter
Truist Financial
|
60
USD
Upside 12% |
5 months ago
Jul 16, 2024
|
Inari Medical price target raised to $60 from $47 at Truist
TheFly
|
|
Adam Maeder
Piper Sandler
|
50
USD
Downside 7% |
7 months ago
May 1, 2024
|
Inari Medical Inc. (NARI) PT Lowered to $50 at Piper Sandler
StreetInsider
|
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is NARI's stock price target?
Price Target
68.19
USD
According to Wall Street analysts, the average 1-year price target for
NARI
is 68.19 USD
with a low forecast of 50.5 USD and a high forecast of 90.3 USD.
What is Inari Medical Inc's Revenue forecast?
Projected CAGR
19%
For the last 4 years the
compound annual growth rate for
Inari Medical Inc's revenue is
76%.
The projected
CAGR
for the next 4 years is
19%.
You don't have any saved screeners yet
